Australia markets closed

GeneTether Therapeutics Inc. (GNTTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.01000.0000 (0.00%)
As of 12:45PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
196.212
196.212
532.839
404.868
59.388
Selling general and administrative
551.065
551.065
1,184
1,232
12.574
Total operating expenses
747.277
747.277
1,717
1,637
71.962
Operating income or loss
-747.277
-747.277
-1,717
-1,637
-71.962
Interest expense
-
-
0
0.282
1.004
Total other income/expenses net
6.76
6.76
-2.858
-0.395
-
Income before tax
-688.359
-688.359
-1,715
-1,638
-72.966
Income from continuing operations
-688.359
-688.359
-1,715
-1,638
-72.966
Net income
-688.359
-688.359
-1,715
-1,638
-72.966
Net income available to common shareholders
-688.359
-688.359
-1,715
-1,638
-72.966
Basic EPS
-0.02
-
-0.04
-0.04
-0.00
Diluted EPS
-0.02
-
-0.04
-0.04
-0.00
Basic average shares
48,969
-
43,074
46,005
46,005
Diluted average shares
48,969
-
43,074
46,005
46,005